Stay updated on Ixazomib Citrate for Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' as a disease descriptor and included a link to the Genetic and Rare Diseases Information Center as a patient resource.
    Difference
    0.1%
    Check dated 2026-03-28T14:03:51.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T09:08:24.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-06T18:26:15.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.4.1 to v3.4.2. No other visible changes to study content or layout are evident.
    Difference
    0.0%
    Check dated 2026-02-13T12:26:12.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page.
    Difference
    0.0%
    Check dated 2026-02-06T00:02:18.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Glossary toggle controls (Show glossary / Hide glossary) were added, and minor wording/capitalization changes were made to update metadata (e.g., Last Update Submitted that Met QC Criteria vs Last Update Submitted that met QC Criteria, No FEAR Act Data vs No FEAR Act data), plus a revision note 'Revision: v3.4.0'. These changes affect presentation and metadata only and do not alter core study content or functionality.
    Difference
    0.2%
    Check dated 2026-01-22T17:45:14.000Z thumbnail image

Stay in the know with updates to Ixazomib Citrate for Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.